Insider Trading History of Bridgebio Pharma, Inc.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Bridgebio Pharma, Inc. since 2018. This trader's CIK number is 1743881. At the time of last reporting, Bridgebio Pharma, Inc. was the 10% Owner of Eidos Therapeutics, Inc.. (stock ticker symbol EIDX). Also see all insider trading activities at Eidos Therapeutics, Inc..


Yearly summary of insider trading at Eidos Therapeutics, Inc. (EIDX) by Bridgebio Pharma, Inc.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 EIDX 14,428,836 $0 0 $0 0 $0
2019 EIDX 1,986,201 $55,006,015 0 $0 0 $0
2018 EIDX 3,853,848 $59,589,910 120,797 $1,656,368 0 $0


Insider trading of Eidos Therapeutics, Inc. (EIDX) by Bridgebio Pharma, Inc.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-01-26 EIDX Buy 14,428,836 .00 0
2019-07-03 EIDX Buy 882,353 29.90 26,383,237
2019-05-24 EIDX Buy 1,103,848 25.93 28,622,778
2018-12-10 EIDX Sale 40,653 13.62 553,897
2018-12-06 EIDX Sale 38,970 13.34 519,859
2018-12-07 EIDX Sale 41,174 14.15 582,612
2018-12-05 EIDX Buy 1,103,848 14.01 15,464,910
2018-12-03 EIDX Buy 1,750,000 15.50 27,125,000
2018-06-22 EIDX Buy 1,000,000 17.00 17,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bridgebio Pharma, Inc. (10% Owner of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.